India is a global leader in the pharmaceutical industry, offering high-quality and affordable medicines. Gefitinib, a targeted therapy for non-small cell lung cancer (NSCLC), is widely produced in India by reputable manufacturers who adhere to international quality standards.
Some of the top Gefitinib tablet manufacturers in India include companies known for their innovation, extensive R&D, and compliance with Good Manufacturing Practices (GMP). These manufacturers focus on producing cost-effective alternatives to branded Gefitinib, ensuring accessibility for patients worldwide.
Their expertise lies in large-scale production, advanced technology, and robust distribution networks that cater to domestic and international markets. Additionally, they prioritize patient safety, rigorous quality checks, and timely delivery of medicines.
Indian manufacturers have established themselves as reliable suppliers, offering Gefitinib in various dosages to meet diverse patient needs, contributing significantly to the global fight against cancer.
The FD is responsible for protection and conservation of biodiversity and sustainable management of forest resources of the country. It performs the protection and production functions in harmony, based on the Forest Policy (1995). While endeavoring to mitigate climate change through sustainable forest management, FD has been making its best efforts to meet the basic needs of local people.
Community Forestry Unit
Forest Department
Building 39,
PO box, 15011 ,
Zarya Htani Road
Ph: and Fax 067 405402
Naypyitaw, MYANMAR